Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3
24/09/2025 07:51
Sept 24 (Reuters) - Implantica AG 8IM1q.F: ANNOUNCES U.S. FDA HAS PROVIDED FEEDBACK ON THE FINAL REFLUXSTOP® PMA SUBMISSION, MODULE 3 FDA PROVIDES FAVORABLE FEEDBACK ON REFLUXSTOP PMA MODULE 3 ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3